Aptahem signs start up agreement with international clinical CRO for phase 1 studies with Apta-1
2022-01-07
Aptahem (publ) announces today that the company has signed an agreement to initiate activities (Start Up Agreement, SUA) with the clinical contract research organization (CRO) The Centre for Human Drug Research (CHDR) in the Netherlands to prepare the upcoming...
Read More